338 related articles for article (PubMed ID: 12177428)
1. Wiskott-Aldrich syndrome protein is required for NK cell cytotoxicity and colocalizes with actin to NK cell-activating immunologic synapses.
Orange JS; Ramesh N; Remold-O'Donnell E; Sasahara Y; Koopman L; Byrne M; Bonilla FA; Rosen FS; Geha RS; Strominger JL
Proc Natl Acad Sci U S A; 2002 Aug; 99(17):11351-6. PubMed ID: 12177428
[TBL] [Abstract][Full Text] [Related]
2. IL-2 induces a WAVE2-dependent pathway for actin reorganization that enables WASp-independent human NK cell function.
Orange JS; Roy-Ghanta S; Mace EM; Maru S; Rak GD; Sanborn KB; Fasth A; Saltzman R; Paisley A; Monaco-Shawver L; Banerjee PP; Pandey R
J Clin Invest; 2011 Apr; 121(4):1535-48. PubMed ID: 21383498
[TBL] [Abstract][Full Text] [Related]
3. The Wiskott-Aldrich syndrome protein regulates nuclear translocation of NFAT2 and NF-kappa B (RelA) independently of its role in filamentous actin polymerization and actin cytoskeletal rearrangement.
Huang W; Ochs HD; Dupont B; Vyas YM
J Immunol; 2005 Mar; 174(5):2602-11. PubMed ID: 15728466
[TBL] [Abstract][Full Text] [Related]
4. Impaired natural and CD16-mediated NK cell cytotoxicity in patients with WAS and XLT: ability of IL-2 to correct NK cell functional defect.
Gismondi A; Cifaldi L; Mazza C; Giliani S; Parolini S; Morrone S; Jacobelli J; Bandiera E; Notarangelo L; Santoni A
Blood; 2004 Jul; 104(2):436-43. PubMed ID: 15001467
[TBL] [Abstract][Full Text] [Related]
5. The mature activating natural killer cell immunologic synapse is formed in distinct stages.
Orange JS; Harris KE; Andzelm MM; Valter MM; Geha RS; Strominger JL
Proc Natl Acad Sci U S A; 2003 Nov; 100(24):14151-6. PubMed ID: 14612578
[TBL] [Abstract][Full Text] [Related]
6. Defective actin polymerization in EBV-transformed B-cell lines from patients with the Wiskott-Aldrich syndrome.
Facchetti F; Blanzuoli L; Vermi W; Notarangelo LD; Giliani S; Fiorini M; Fasth A; Stewart DM; Nelson DL
J Pathol; 1998 May; 185(1):99-107. PubMed ID: 9713366
[TBL] [Abstract][Full Text] [Related]
7. Impaired NK-cell migration in WAS/XLT patients: role of Cdc42/WASp pathway in the control of chemokine-induced beta2 integrin high-affinity state.
Stabile H; Carlino C; Mazza C; Giliani S; Morrone S; Notarangelo LD; Notarangelo LD; Santoni A; Gismondi A
Blood; 2010 Apr; 115(14):2818-26. PubMed ID: 20130240
[TBL] [Abstract][Full Text] [Related]
8. Defective actin accumulation impairs human natural killer cell function in patients with dedicator of cytokinesis 8 deficiency.
Mizesko MC; Banerjee PP; Monaco-Shawver L; Mace EM; Bernal WE; Sawalle-Belohradsky J; Belohradsky BH; Heinz V; Freeman AF; Sullivan KE; Holland SM; Torgerson TR; Al-Herz W; Chou J; Hanson IC; Albert MH; Geha RS; Renner ED; Orange JS
J Allergy Clin Immunol; 2013 Mar; 131(3):840-8. PubMed ID: 23380217
[TBL] [Abstract][Full Text] [Related]
9. Mosaicism of NK cells in a patient with Wiskott-Aldrich syndrome.
Lutskiy MI; Beardsley DS; Rosen FS; Remold-O'Donnell E
Blood; 2005 Oct; 106(8):2815-7. PubMed ID: 15985539
[TBL] [Abstract][Full Text] [Related]
10. [Molecular pathogenesis of Wiskott-Aldrich syndrome].
Sasahara Y; Tsuchiya S
Nihon Rinsho Meneki Gakkai Kaishi; 2005 Jun; 28(3):140-7. PubMed ID: 15997177
[TBL] [Abstract][Full Text] [Related]
11. Wiskott-Aldrich Syndrome: a model for defective actin reorganization, cell trafficking and synapse formation.
Notarangelo LD; Ochs HD
Curr Opin Immunol; 2003 Oct; 15(5):585-91. PubMed ID: 14499269
[TBL] [Abstract][Full Text] [Related]
12. The Wiskott-Aldrich syndrome protein (WASP): roles in signaling and cytoskeletal organization.
Snapper SB; Rosen FS
Annu Rev Immunol; 1999; 17():905-29. PubMed ID: 10358777
[TBL] [Abstract][Full Text] [Related]
13. IL-2 in the tumor microenvironment is necessary for Wiskott-Aldrich syndrome protein deficient NK cells to respond to tumors in vivo.
Kritikou JS; Dahlberg CI; Baptista MA; Wagner AK; Banerjee PP; Gwalani LA; Poli C; Panda SK; Kärre K; Kaech SM; Wermeling F; Andersson J; Orange JS; Brauner H; Westerberg LS
Sci Rep; 2016 Aug; 6():30636. PubMed ID: 27477778
[TBL] [Abstract][Full Text] [Related]
14. WASP (Wiskott-Aldrich syndrome protein) gene mutations and phenotype.
Imai K; Nonoyama S; Ochs HD
Curr Opin Allergy Clin Immunol; 2003 Dec; 3(6):427-36. PubMed ID: 14612666
[TBL] [Abstract][Full Text] [Related]
15. [Identification of two novel WASP gene mutations in 3 boys with Wiskott-Aldrich syndrome].
Jiang LP; Xu YH; Yang XQ; Liu EM; Wang LJ; Lau YL; Chan KW
Zhonghua Er Ke Za Zhi; 2003 Aug; 41(8):590-3. PubMed ID: 14744380
[TBL] [Abstract][Full Text] [Related]
16. The Wiskott-Aldrich syndrome.
Ochs HD; Thrasher AJ
J Allergy Clin Immunol; 2006 Apr; 117(4):725-38; quiz 739. PubMed ID: 16630926
[TBL] [Abstract][Full Text] [Related]
17. Mutations of the Wiskott-Aldrich Syndrome Protein affect protein expression and dictate the clinical phenotypes.
Ochs HD
Immunol Res; 2009; 44(1-3):84-8. PubMed ID: 19082760
[TBL] [Abstract][Full Text] [Related]
18. The pleckstrin homology domain of the Wiskott-Aldrich syndrome protein is involved in the organization of actin cytoskeleton.
Imai K; Nonoyama S; Miki H; Morio T; Fukami K; Zhu Q; Aruffo A; Ochs HD; Yata J; Takenawa T
Clin Immunol; 1999 Aug; 92(2):128-37. PubMed ID: 10444357
[TBL] [Abstract][Full Text] [Related]
19. Retrovirus-mediated WASP gene transfer corrects Wiskott-Aldrich syndrome T-cell dysfunction.
Wada T; Jagadeesh GJ; Nelson DL; Candotti F
Hum Gene Ther; 2002 Jun; 13(9):1039-46. PubMed ID: 12067437
[TBL] [Abstract][Full Text] [Related]
20. Fyn and PTP-PEST-mediated regulation of Wiskott-Aldrich syndrome protein (WASp) tyrosine phosphorylation is required for coupling T cell antigen receptor engagement to WASp effector function and T cell activation.
Badour K; Zhang J; Shi F; Leng Y; Collins M; Siminovitch KA
J Exp Med; 2004 Jan; 199(1):99-112. PubMed ID: 14707117
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]